Related by context. All words. (Click for frequent words.) 70 inecalcitol 69 Apoptone 69 pharmacologically active isomer 68 CTAP# Capsules 67 generation purine nucleoside 67 nitric oxide donating prostaglandin 67 Pitavastatin 67 2 methoxyestradiol #ME# 67 Ciclesonide 66 vidofludimus 66 alkylating agent 66 liposomal formulation 66 paricalcitol 65 selective modulator 65 Nestorone 65 OMP #M# 65 Xanafide 65 IMiDs ® 65 Darinaparsin 65 epothilone 65 LAB CGRP 65 CG# [003] 65 LB# [003] 65 prostone 65 subcutaneously administered 65 maximally tolerated dose 64 goserelin 64 Anticalins ® 64 Panzem R NCD 64 GLP1 64 metaglidasen 64 DCCR 64 ceftazidime 64 MAGE A3 ASCI 64 pan HDAC inhibitor 64 lanthanum carbonate 64 Interferon alpha 64 pharmacodynamic PD 64 AKT inhibitor 64 Archexin 64 MEK inhibitors 64 topical formulations 64 HCV protease inhibitors 64 Ophena TM 64 5 HT2C receptor 64 GV# [001] 64 PDE4 inhibitor 64 ritonavir boosted 64 granisetron 63 Elvitegravir 63 rHuPH# 63 Anticalins R 63 #ME# 63 BAL# [002] 63 leukotriene receptor antagonist 63 Dasatinib 63 acitretin 63 Squalamine 63 prucalopride 63 ospemifene 63 SCIg 63 GHRH 63 AEG# 63 strontium ranelate 63 MGd 63 nucleotide analog 63 relapsed MM 63 subcutaneously injected 63 receptor blocker 63 Symadex 63 Pathway Inhibitor 63 YONDELIS 63 immune modulatory 63 calcitonin 63 TNF alpha inhibitor 63 verteporfin 63 ALB # 63 parthenolide 63 pharmacokinetic PK profile 63 vascular disrupting agents 63 PEGylated interferon 63 antimitotic 63 viral kinetics 63 INT# [002] 63 elvitegravir 63 sodium glucose cotransporter 63 proteasome inhibitor 63 SERMs 63 Pterostilbene 63 antithrombotic 63 Orally administered 63 Fluticasone 63 mertansine 63 calcipotriene 62 parathyroid hormone PTH 62 TPI ASM8 62 NN# [001] 62 novel VDA molecule 62 prostanoid 62 LT NS# 62 liposome encapsulated 62 JAK inhibitors 62 Dapagliflozin 62 M1 muscarinic 62 plasma pharmacokinetics 62 Protelos 62 Tasimelteon 62 favorable pharmacokinetic 62 VA# [002] 62 indibulin 62 radiolabeled 62 Preclinical studies suggest 62 oral salmon calcitonin 62 pegylated 62 ESBA# 62 isoproterenol 62 aleglitazar 62 antiarrhythmic agent 62 Lubiprostone 62 thrombopoietin 62 soft gelatin capsule 62 somatostatin analog 62 S/GSK# 62 evaluating tivozanib 62 PI3K/mTOR 62 tacrolimus ointment 62 latanoprost 62 Onconase 62 Belerofon 62 Accordion Pill 62 immune modulating 62 Solulin 62 Kahalalide F 62 APTIVUS 62 pharmacokinetic characteristics 62 HQK 62 neuroprotective properties 62 afamelanotide 62 selective androgen receptor modulator 62 pharmacodynamic properties 62 interferon alfa 2b 62 besylate 62 oral prodrug 62 tNOX 62 antiproliferative effects 62 XmAb# 62 Vidaza azacitidine 62 pyridostigmine 62 interferon gamma 1b 62 GLYX 62 orally inhaled 62 PSN# [002] 62 RLY# 62 oral antidiabetic 62 bepotastine besilate 62 capsule formulation 62 PTHrP 62 peptide conjugated 62 dopamine partial agonist 62 ENMD # 62 protein tyrosine phosphatase 1B 62 Epanova 62 demonstrated antitumor activity 62 plasma lipid 62 insulin lispro 61 hPTH #-# 61 bortezomib Velcade 61 SPRIX ® 61 dexamethasone Decadron 61 corticosteroid dexamethasone 61 busulfan 61 Lixivaptan 61 betamethasone dipropionate 61 topical antifungal 61 AAG geldanamycin analog 61 chimeric monoclonal antibody 61 dasatinib Sprycel 61 nanomolar 61 Aganocide 61 Sudhir Agrawal D.Phil 61 cardioprotective effects 61 ibandronate 61 pitavastatin 61 PrevOnco ™ 61 Tß4 61 alkylating 61 Pimavanserin 61 PI3K inhibitor 61 Soriatane 61 2A receptor agonist 61 bardoxolone 61 GAMMAGARD 61 PRT# 61 ciclopirox 61 caspofungin 61 statin simvastatin 61 JAK inhibitor 61 cytostatic 61 Recombinant Human 61 EZN 61 nucleoside analogs 61 humanized monoclonal 61 TLR9 agonist 61 Androxal TM 61 Darusentan 61 Silodosin 61 mTOR inhibitors 61 pharmacodynamic effects 61 antiangiogenic therapy 61 trabectedin 61 PSMA ADC 61 YONDELIS R 61 Hsp# Inhibitor 61 Ophena 61 Sanvar R 61 synthetic retinoid 61 dose proportionality 61 Personalized Immunotherapy 61 bovine thrombin 61 zoledronate 61 OvaRex ® MAb 61 ARIKACE ™ 61 Menadione 61 Ozarelix 61 androgen receptor antagonist 61 Amrubicin 61 cephalosporin antibiotics 61 eniluracil 61 bezafibrate 61 HuLuc# 61 uroguanylin 61 CYT# potent vascular disrupting 61 CBLC# 61 LHRH antagonists 61 double blinded placebo 61 Vascugel 61 topical retinoid 61 iSONEP 61 topically administered 61 Panzem R 61 Traficet EN 61 EOquin TM 61 receptor tyrosine kinase inhibitor 61 potent antiproliferative 61 potency selectivity 61 Sym# 61 cyanocobalamin 61 pharmacokinetic equivalence 61 Ostabolin C TM 61 receptor inhibitor 61 Lispro 61 multidose 61 Genz # 61 Intravenous CP 61 somatostatin 61 vivo potency 61 TOCOSOL Camptothecin 61 NeuroSTAT ® 61 MEK inhibitor 61 small molecule activators 61 cannabinor 61 Tyrima 61 Fodosine 61 torezolid 61 IFN beta 61 beta interferons 61 microtubule inhibitor 61 SLx 61 inhaled iloprost 61 Kinoid 61 interferon IFN 61 teriflunomide 61 intranasal formulation 61 cobalamin 61 pharmacokinetic interactions 61 norethindrone acetate 61 Zemplar Capsules 61 ciclesonide 61 mecamylamine 61 topoisomerase II inhibitor 61 TBC# 61 Phase III Clinical Trials 61 topical ophthalmic 61 prasterone 61 PRLX # 61 DPP4 60 liposome formulation 60 fosbretabulin 60 intradermal injection 60 radezolid 60 kinase inhibition 60 Sanofi Pasteur Fluzone 60 clotrimazole 60 Raltegravir 60 HuMax CD4 60 ARRY # 60 vapreotide acetate 60 novel orally bioavailable 60 oral rivaroxaban 60 antiresorptive 60 administered intranasally 60 glutamyl 60 lyophilised 60 radiotherapeutic 60 aripiprazole Abilify 60 EVIZON 60 orally disintegrating 60 RESOLOR 60 insulin aspart 60 abacavir lamivudine 60 retinoid 60 MTP inhibitor 60 RSD# oral 60 miglustat 60 Plicera 60 subtype selective 60 Posiphen 60 IAP inhibitors 60 cromolyn sodium 60 salmon calcitonin 60 miconazole Lauriad ® 60 CCR9 antagonist 60 phase IIb trial 60 DermaVir Patch 60 nucleoside analog 60 FOSRENOL ® 60 Platinol 60 anticancer compound 60 Glucagon Like Peptide 60 GelVac TM 60 ocular formulation 60 non nucleoside 60 Octreotide 60 PEG SN# 60 Natural S equol 60 Myolimus 60 TriRima 60 humanised antibody 60 antiangiogenic 60 intranasal delivery 60 vinca alkaloid 60 defensin mimetic antibiotic 60 gonadotrophin releasing hormone GnRH 60 PGL# 60 Elagolix 60 ESTRASORB 60 delafloxacin 60 antitumor effect 60 luliconazole 60 chemopreventive agent 60 enzyme cofactor 60 R#/MEM # 60 small molecule Hedgehog 60 Plenaxis TM 60 lenalidomide dexamethasone 60 hyperphenylalaninemia HPA due 60 synthetic siRNA 60 PRTX 60 injectable formulations 60 triglyceride lowering 60 Diamyd R 60 sevelamer 60 CANCIDAS 60 Ganciclovir 60 Guanilib 60 exendin 4 60 Lipoic acid 60 urocortin 2 60 HCV replicon 60 mesylate 60 orally administered inhibitor 60 peptide antigens 60 eprotirome 60 beta 1a 60 volociximab 60 NXL# 60 paclitaxel Taxol ® 60 VEGF inhibitors 60 daunorubicin 60 administered subcutaneously 60 fluoroquinolone antibiotic 60 unconjugated 60 Fulvestrant 60 SAMe 60 Genasense ® oblimersen 60 vascular disrupting agent 60 nasal antihistamine 60 Granulocyte Colony Stimulating Factor 60 IPL# 60 potent suppressor 60 torezolid phosphate 60 Maribavir 60 selective antagonist 60 SinuNase ™ 60 pegylated IFN 60 epigenetic therapies 60 Imprime PGG 60 Onalta 60 Poly ICLC 60 nitazoxanide 60 insulin sensitizing 60 #beta HSD 1 60 nucleoside reverse transcriptase inhibitor 60 tubulin inhibitor 60 Epothilones 60 macrolide antibiotic 60 TH# [003] 60 nalbuphine ER 60 ART# 60 dosage regimens 60 BXT # 60 anti resorptive 60 Panzem 60 #HT#A 60 NRTI resistance 60 PHX# 60 Marqibo TM 60 immunomodulator 60 antitumor effects 60 Blinatumomab 60 synthetic peptides 60 Privigen 60 Cloretazine 60 Bortezomib 60 HDACi 60 inhaled formulation 60 Pertuzumab 60 BioSilicon 60 generation FBPase inhibitor 60 HSP# inhibitor 60 bronchodilatory 60 eosinophil count 60 pegylated liposomal doxorubicin 60 daily subcutaneous injections 60 somatostatin analogue 60 GLP1 agonist 60 Aptivus ® 60 TAFA# 60 Sapacitabine 60 Vaxfectin 60 Rigel R# 60 selective kinase inhibitor 60 Natalizumab 60 amifostine 60 azilsartan medoxomil 60 ATL# [002] 60 multitargeted 60 Oral Insulin 60 danoprevir 60 diarrhea predominant irritable 60 pimecrolimus 60 PS# [001] 60 LHRH receptor positive 60 trospium 60 Aurora Kinase 60 Darapladib 60 RNAi therapeutic targeting PCSK9 60 2 methoxyestradiol 60 ThGRF 60 5 HT3 antagonist 60 liposomal doxorubicin 60 KSP inhibitor 60 Mipomersen 60 GnRH antagonist 60 PEG IFN 60 HMG CoA reductase inhibitors 60 β blockers 59 Valdoxan 59 Alzhemed TM 59 cyclophilin inhibitor 59 selective orally bioavailable 59 SGLT 59 desonide 59 Carvedilol 59 rhGH 59 Omacetaxine mepesuccinate 59 topical diclofenac 59 Cleviprex TM clevidipine 59 cediranib 59 hyaluronidase enzyme 59 CCX# 59 cathepsin K inhibitor 59 Vilazodone 59 Voreloxin 59 prostaglandin E1 59 efavirenz EFV 59 intravesical instillation 59 oral transmucosal 59 potentiator 59 preclinically 59 diabetic neuropathic pain 59 glucuronide 59 intracellular uptake 59 vancomycin hydrochloride 59 preclinical efficacy 59 galiximab 59 Calcitonin 59 ancrod 59 sitosterol 59 pharmacokinetic profile 59 irbesartan 59 acyclovir Lauriad R 59 photosensitizing 59 CDK inhibitor 59 NOX E# 59 HepDirect prodrug 59 Formoterol 59 #beta estradiol 59 TLR agonists 59 resolvin 59 Fortical R 59 racemic 59 Solorel TM 59 IMiDs ® compound 59 forodesine 59 enzyme inhibitor 59 guanosine 59 APTIVUS r 59 trastuzumab emtansine T DM1 59 salmeterol fluticasone 59 zileuton 59 Cellegesic 59 HuMax CD# 59 Tarceva TM 59 Zybrestat 59 UDCA 59 siRNAs targeting 59 LNP formulations 59 metabolomic profiles 59 tranilast 59 Angiotensin Converting Enzyme 59 antiarrhythmic 59 PEGylated 59 5 HT2A inverse 59 diclofenac sodium 59 CIMZIA R 59 rhIGF-I/rhIGFBP-3 59 histone deacetylase HDAC 59 lipid particle 59 Virulizin ® 59 Bezielle 59 oleanolic acid 59 synthetic peptide containing 59 5 HT2A serotonin 59 plasma lipoprotein 59 anti CD3 59 Factor Xa inhibitor 59 CLORETAZINE TM VNP#M 59 RhuDex ® 59 selective estrogen receptor modulator 59 trospium chloride 59 Icatibant 59 peptidomimetic 59 phosphate binding 59 peptidic 59 Luteinizing Hormone Releasing Hormone 59 latrepirdine 59 Factor VIIa 59 PD LID 59 MBP# [001] 59 novel immunomodulatory 59 5 HT2A 59 lomitapide 59 potent topoisomerase II 59 steroid dexamethasone 59 LibiGel ® 59 ritonavir boosted protease inhibitor 59 balsalazide tablet 59 Evoltra ® 59 uric acid lowering 59 antifolate 59 Vidofludimus 59 ergocalciferol 59 small molecule thrombopoietin 59 PXD# 59 GSK3B 59 #.#mg 1mg 59 novel prodrug 59 subcutaneous SC 59 heparanase 59 tasimelteon 59 TKB# 59 CaPre TM 59 HGS# 59 INCB# [001] 59 elastase 59 rxRNA 59 targeted antifolate 59 Hizentra 59 Nasulin ™ 59 CoFactor 59 trastuzumab Herceptin ® 59 Rebif ® 59 synthetic progestin 59 IMiDs R 59 tecarfarin 59 fluvastatin 59 clade B 59 Thiovir 59 decitabine 59 PPAR gamma agonists 59 gallium containing 59 antiandrogens 59 FTY# fingolimod 59 Denufosol 59 MIRCERA 59 sorafenib tablets 59 intravenous formulations 59 PROCHYMAL 59 Phase Ib II 59 tubulin inhibitors 59 interleukin IL 59 Benazepril 59 trastuzumab DM1 59 trandolapril 59 alvespimycin 59 Pemetrexed 59 thymalfasin 59 targeted radiotherapeutic 59 RezularTM 59 immuno modulatory 59 NEBIDO 59 omiganan 59 Tekamlo 59 synthetic peptide 59 macrolide antibiotics 59 peripherally acting 59 HMG CoA reductase inhibitor 59 metreleptin 59 serotonin norepinephrine reuptake inhibitor 59 proprietary encapsulation 59 CCR5 antagonist 59 idraparinux 59 NGX# 59 metformin XR 59 nucleoside nucleotide 59 fenofibric acid 59 RoACTEMRA 59 GFT# 59 selectively inhibits 59 triphendiol 59 Locked Nucleic Acid LNA 59 estramustine 59 uricase 59 PKC# 59 elotuzumab 59 Zoraxel 59 VAPRISOL 59 non nucleoside inhibitor 59 ORENCIA R 59 pharmacodynamic parameters 59 cinacalcet 59 CYP #A# 59 pain palliation 59 sirolimus 59 orally bioavailable 59 insulin degludec 59 transdermal gel 59 Akt inhibitor 59 serum lipid 59 agonist antagonist 59 insulin analogs 59 Novasome R 59 apolipoprotein B 59 RH1 59 PI3K inhibitors 59 Multimeric 59 mu opioid 59 UPLYSO 59 PI3K/Akt pathway inhibitor 59 peptibody 59 systemic antifungal 59 subcutaneous immunoglobulin 59 Japanese Encephalitis vaccine 59 fumarate 59 Androxal ® 59 regorafenib 59 mucoregulator 59 renin inhibitors 59 FOSRENOL R 59 pharmacokinetic PK 59 Tamibarotene 59 VivaGel TM 59 USL# 59 serotonin synthesis 59 AQ4N 59 COREG CR 59 Zysolin TM 59 Atripla combines 59 cilengitide 59 octreotide acetate 59 Anavex #-# 59 bazedoxifene selective estrogen receptor 59 beta2 agonist 59 ixabepilone 59 oral immunomodulatory 59 GAP #B# 59 Enhanze Technology 59 stavudine d4T 59 midstage clinical 59 Biolimus A9 59 oral renin inhibitor 59 sitaxsentan 59 Sumatriptan OS 59 PPARg 59 ORENCIA ® 59 bendamustine 59 Phase IIIb clinical 59 TransVax tm 59 Technosphere ® 59 antidiabetic 59 fluticasone furoate 59 protease inhibitor PI 59 direct thrombin inhibitors 59 osteogenic 59 tolevamer 59 CRD5 59 desvenlafaxine succinate 59 HCl capsules 59 teduglutide 58 RECOTHROM R 58 DAVANAT 58 sulfonylhydrazine class 58 adipogenic 58 orally dosed 58 phase IIa clinical 58 sodium glucose transporter 58 Presents Preclinical 58 dopamine D2 58 entinostat 58 Cetrorelix 58 Phase Ib study 58 nucleoside 58 neratinib 58 cidofovir 58 topical ocular 58 thromboxane A2 58 palonosetron 58 Phase 1a clinical 58 gliclazide 58 analgesic efficacy 58 GSK# [001] 58 ACTEMRA TM 58 Alvesco R 58 Amigal 58 systemically administered 58 pharmacokinetics PK 58 SERCA2a 58 leukotriene 58 favorable pharmacokinetic profile 58 Phase #b/#a trial 58 ALK inhibitors 58 depsipeptide 58 Phase Ib clinical 58 S equol 58 anti angiogenic agent 58 huN# DM1 58 antiandrogen 58 epoetin alpha 58 Triapine R 58 dihydrochloride 58 R roscovitine 58 Cathepsin S 58 BMS# 58 Anticalins 58 docetaxel Taxotere ® 58 potent anticancer 58 murine model 58 monohydrate 58 ZACTIMA 58 Allovectin 7 ® 58 1mg 2mg 58 atazanavir ritonavir 58 plasma kallikrein inhibitor 58 vitro assay 58 tolerability profiles 58 multicenter Phase III 58 refractory prostate cancer 58 sulindac 58 solithromycin 58 β carotene 58 Omnaris 58 DermaVir 58 PRX# 58 riociguat 58 Deforolimus 58 Alfacell proprietary ribonuclease 58 Aliskiren 58 nicotinic acid 58 enzyme inhibitors 58 phase IIb clinical 58 Glufosfamide 58 buccal delivery 58 lasofoxifene 58 Aflibercept 58 human microdosing 58 Tracleer R 58 TG# [003] 58 PEGylated anti 58 SAR# [004] 58 glycosylated hemoglobin levels 58 bepotastine 58 Cethrin R 58 azelastine 58 alicaforsen enema 58 Cand5 58 platinum chemotherapeutic 58 highly immunogenic 58 ethyl EPA 58 nadolol 58 asparaginase 58 serum phosphorus 58 oxybutynin gel 58 Omacetaxine 58 anti amnesic 58 replicon 58 Venlafaxine 58 ALVESCO HFA 58 racemic baclofen 58 chemotherapeutic drug 58 cis retinoic acid 58 AZILECT R 58 xanthine oxidase inhibitor 58 TELINTRA 58 injected subcutaneously 58 cytoprotective 58 immunomodulation 58 5 HT2A receptor 58 Triolex 58 Pharmacokinetic studies 58 Tredaptive 58 levocetirizine 58 lipid nanoparticle 58 dalbavancin 58 Zonisamide 58 Pennsaid R 58 benzimidazole 58 calcitonin gene related 58 peptide fragment 58 Apaziquone 58 antitumoral 58 histrelin 58 Anidulafungin 58 epinastine 58 pafuramidine 58 tumorigenicity 58 renin inhibitor 58 Vaxfectin R 58 nucleosides 58 pathophysiological effects 58 methylnaltrexone bromide 58 Elacytarabine 58 #mg dose [001] 58 IFN alpha 58 Elocalcitol 58 IV Busulfex 58 Cefazolin 58 Lovaza ® 58 calcitriol 58 DB# [003] 58 CYT# QbG# 58 antifolates 58 Cethromycin 58 Bicifadine 58 DU #b 58 CELVAPAN H#N# 58 inverse agonist 58 immunomodulatory effects 58 Spiegelmer ® 58 GMX# 58 buccal spray 58 small molecule agonists 58 TLR8 agonist 58 OHR/AVR# 58 zotarolimus 58 itraconazole Sporanox 58 pharmacokinetic properties 58 prescribed proton pump 58 TRO# 58 RiVax 58 Apoptone HE# 58 Dual Opioid 58 Cannabinor 58 long acting muscarinic 58 6mg 58 effector function 58 Febuxostat 58 polymerase inhibitors 58 5 HT6 receptor 58 Diamyd ® 58 guanfacine 58 DPP4 inhibitor 58 Milnacipran 58 Amplimexon 58 castrate resistant prostate cancer 58 LY# [003] 58 BRAF inhibitor 58 gemcitabine Gemzar ® 58 SGLT 2 58 HSP# inhibitors 58 ATL# [001] 58 sorafenib Nexavar ® 58 paclitaxel poliglumex 58 visilizumab 58 azelaic acid 58 Vernakalant 58 antisense inhibitors 58 Phase Ia 58 basal insulin analogue 58 trials RCTs 58 ADP receptor antagonist 58 proteasome inhibitors 58 MP4OX 58 intravenous dosing 58 enzastaurin 58 Novolimus 58 MitoQ 58 Nascobal 58 antiangiogenic agents 58 Relivar 58 Increlex R 58 oral antiviral 58 incyclinide 58 JVRS 58 pharmacokinetic PK study 58 Bevirimat 58 potentially hepatotoxic 58 RE LY trial 58 ibudilast 58 TEMODAL 58 antiangiogenesis 58 DP b# 58 apomorphine 58 peroxidase 58 Civacir 58 elvucitabine 58 FOLOTYN ® 58 Tolevamer 58 systemic bioavailability 58 oxcarbazepine 58 Panzem NCD 58 ABILIFY ® 58 Sphingomab 58 olmesartan 58 selectively inhibited 58 racemic mixture 58 Systemic Delivery 58 monomeric 58 Restoraderm 58 KRAS mutations occur 58 HIF PH inhibitors 58 melphalan prednisone 58 Hsp# inhibitors 58 Adenoscan R 58 antitumor efficacy 58 HGS ETR1 mapatumumab 58 nelfinavir 58 Naproxcinod 58 pharmacologically active 58 HuMax EGFr 58 Iloperidone 58 Levemir R 58 lucinactant 58 recombinant human 58 carbohydrate polymer 58 NS#/#A protease 58 GLP toxicology studies 58 Phase 2b study 58 ongoing Phase 1b 58 micafungin 58 cefixime 58 Fenretinide 58 Myocet 58 delta opioid receptor 58 ulimorelin 58 SAR# [002] 58 tetracycline antibiotic 58 BMS # 58 erlotinib Tarceva ® 58 safety tolerability pharmacokinetic 58 IAP inhibitor 58 quinoline 58 serum concentrations 58 radiolabeled antibody 58 pyrimidines 58 Meets Primary Endpoint 58 vinorelbine tartrate 58 Sitagliptin 58 hereditary deficiency 58 etanercept Enbrel 58 transdermal spray 58 AZILECT ® 58 retaspimycin 58 topical formulation 58 CA4P 58 Estradiol 58 urate lowering 58 Chemophase 58 HBV vaccine